Published
Video length: 1 min.
Vaccines to fight against bronchiolitis in infants or bronchitis in the elderly are eagerly awaited. The European Medicines Agency has just approved the product from the Pfizer laboratory. The point with the journalist and doctor Damien Mascret, present on the set of 20 Hours, Monday July 24.
“Last fall, 26,000 children under the age of two were hospitalized with bronchiolitis.“recalls first of all the doctor and journalist Damien Mascret, present on the set of 20 Heures, Monday July 24. However, babies will not be directly vaccinated against RSV (respiratory syncytial virus). The vaccine will, indeed, begiven to pregnant women to protect their babies from birth thanks to maternal antibodies. This vaccine will also be intended for people aged 60 and over, in whom the RSV causes bronchitis and sometimes fatal pneumonia“, he specifies.
A 69% reduction in severe bronchiolitis
What about efficiency? “By vaccinating pregnant women, we obtain a 69% reduction in severe bronchiolitis in infants under 6 months. In people over 60, vaccination also reduces the risk of bronchitis and pneumonia by 66%.says the journalist. As for the risks involved, there would have “a statistically non-significant increase in the risk of preterm delivery of 4.7%“.
Among our sources:
Non-exhaustive list.